Literature DB >> 3040208

Relapse-associated variables in stage I favorable histology Wilms' tumor. A report of the National Wilms' Tumor Study.

D A Weeks, J B Beckwith, D W Luckey.   

Abstract

All 24 cases of confirmed and evaluable Stage I favorable histology (FH) Wilms' tumor (WT) relapsing to date on the Third National Wilms' Tumor Study (NWTS-3) were compared with 48 matched control subjects who had not relapsed for at least 2 years after diagnosis. Fifteen of the clinical and pathological variables studied, including patient age and tumor size, had no significant relationship to the outcome of this study. Four histologic features, all related to the degree of tumor extension within the "tumor-kidney unit" proved to be significantly associated with relapse. These were (1) invasion of the tumor capsule, (2) presence of an "inflammatory pseudocapsule," (3) renal sinus invasion, and (4) tumor in intrarenal vessels. One or more of these features was present in 100% of relapsed cases (excluding one for which two variables were unevaluable), but occurred in only 46% of controls (P less than 0.0002). Therefore, no relapses occurred in the NWTS-3 when all four variables were negative. This result was confirmed by a review of all Stage I cases in the NWTS-1 who had relapsed and who were treated by single-agent chemotherapy. Again, no relapses occurred when all four factors were negative. These results demonstrate the feasibility of "microsubstaging" and could serve as a basis for future refinements of therapy for Stage I favorable histology Wilms' tumor.

Entities:  

Mesh:

Year:  1987        PMID: 3040208     DOI: 10.1002/1097-0142(19870915)60:6<1204::aid-cncr2820600608>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis.

Authors:  S Gururangan; A Dorman; R Ball; B Curran; M Leader; F Breatnach; A O'Meara
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

2.  Pulmonary metastases after nephrectomy only for small, stage I/favorable-histology Wilms' tumor.

Authors:  Toshiji Shitara; Yoshiaki Tsuchida; Junko Hirato; Akira Shimada; Hideaki Murai; Norio Suzuki; Minoru Kuroiwa; Mayumi Iwakawa
Journal:  Pediatr Surg Int       Date:  2005-04-15       Impact factor: 1.827

3.  Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.

Authors:  Robert C Shamberger; James R Anderson; Norman E Breslow; Elizabeth J Perlman; J Bruce Beckwith; Michael L Ritchey; Gerald M Haase; Milton Donaldson; Paul E Grundy; Robert Weetman; Max J Coppes; Marcio Malogolowkin; Patricia D Shearer; Morris Kletzel; Patrick R M Thomas; Roger Macklis; Vicki Huff; Douglas A Weeks; Daniel M Green
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

4.  How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study Group.

Authors:  J J Groot-Loonen; C R Pinkerton; P H Morris-Jones; J Pritchard
Journal:  Arch Dis Child       Date:  1990-09       Impact factor: 3.791

5.  A Novel Inflammation-Related Gene Signature for Overall Survival Prediction and Comprehensive Analysis in Pediatric Patients with Wilms Tumor.

Authors:  Jiahao Zhang; Yongchang Lai; Langjing Zhu; Zechao Lu; Chuxian Hu; Haobin Zhou; Zeguang Lu; Zhicheng Tang; Zhaohui He; Fucai Tang
Journal:  Dis Markers       Date:  2022-05-07       Impact factor: 3.464

6.  Recent experience with Wilms' tumor: 1978-1991.

Authors:  R C Shamberger; R M Macklis; S E Sallan
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.